July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
A specific IKKβ inhibitor suppresses experimental autoimmune uveoretinitis in mice
Author Affiliations & Notes
  • Ye Liu
    Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology Hokkaido University,Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, HOKKAIDO, Japan
  • Nobuyoshi Kitaichi
    Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology Hokkaido University,Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, HOKKAIDO, Japan
    Department of Ophthalmology, Health Sciences University of Hokkaido, Sapporo, Hokkaido, Japan
  • Di Wu
    Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology Hokkaido University,Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, HOKKAIDO, Japan
  • Keitaro Hase
    Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology Hokkaido University,Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, HOKKAIDO, Japan
  • Daiju Iwata
    Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology Hokkaido University,Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, HOKKAIDO, Japan
  • Kenichi Namba
    Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology Hokkaido University,Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, HOKKAIDO, Japan
  • Atsuhiro Kanda
    Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology Hokkaido University,Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, HOKKAIDO, Japan
  • Kousuke Noda
    Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology Hokkaido University,Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, HOKKAIDO, Japan
  • Susumu Ishida
    Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology Hokkaido University,Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, HOKKAIDO, Japan
  • Footnotes
    Commercial Relationships   Ye Liu, None; Nobuyoshi Kitaichi, None; Di Wu, None; Keitaro Hase, None; Daiju Iwata, None; Kenichi Namba, None; Atsuhiro Kanda, None; Kousuke Noda, None; Susumu Ishida, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 791. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ye Liu, Nobuyoshi Kitaichi, Di Wu, Keitaro Hase, Daiju Iwata, Kenichi Namba, Atsuhiro Kanda, Kousuke Noda, Susumu Ishida; A specific IKKβ inhibitor suppresses experimental autoimmune uveoretinitis in mice. Invest. Ophthalmol. Vis. Sci. 2019;60(9):791. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Experimental autoimmune uveoretinitis (EAU) is a widely used animal model to investigate human endogenous uveitis, in which the transcriptional factor nuclear factor-κB (NF-κB) is involved in its pathogenesis. Activation of IκB kinase (IKK) degrades IκB, resulting in NF-κB translocation to nuclei and leading to expression of pro-inflammatory cytokines and the subsequent inflammatory process. In the current study, the therapeutic effects of a specific IKKβ inhibitor, IMD-0354, was examined in EAU.

Methods : EAU was induced in B10.BR mice by injection of interphotoreceptor retinoid binding protein derived K2 peptide emulsified with complete Freund’s adjuvant. Bordetella pertussis toxin was also injected as an additional adjuvant. IMD-0354 (30 mg/kg) was injected intraperitoneally every 3 days. Clinical and histopathological severities were graded. Translocation of NF-κB p65 into the nuclei was assessed by immunohistochemistry. T cells were collected from draining lymph nodes of the immunized mice to examine antigen-specific T-cell proliferation and inflammatory cytokine production in vitro.

Results : IMD-0354-treated mice exhibited milder EAU clinical severity (Ave; 1.8+0.45) and histopathological severity (Ave; 0.63+0.44), compared to the controls (Ave; clinical severity:3.2+0.63; histological severity; 2.6+0.84, p<0.01). Inhibition of NF-κB p65 translocation into the nuclei of retina was observed (p<0.01). No significant difference was observed in the antigen-specific T cell proliferation between treated and control groups. IMD-0354 treatment significantly suppressed inflammatory cytokines including tumor necrosis factor alpha alpha, interferon gamma, interleukin 1 alpha, interleukin 6, interleukin-17A, compared to that of controls.

Conclusions : Administration of the specific IKKβ inhibitor, IMD-0354, significantly inhibited NF-κB translocation into the retina, which subsequently suppressed the inflammatory response in EAU model. These results suggest that IMD-0354 is a promising therapeutic agent for endogenous uveitis.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×